| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 4156343 | Journal of Pediatric Surgery | 2013 | 5 Pages | 
Abstract
												Intravenous fish oil (FO) has changed the management of intestinal failure associated liver disease (IFALD). This report describes two IFALD patients who received FO for 5 and 10 months, respectively and reports on their 3-year follow-up.
Keywords
												
											Related Topics
												
													Health Sciences
													Medicine and Dentistry
													Perinatology, Pediatrics and Child Health
												
											Authors
												Kara Calkins, Allison Lowe, Stephen B. Shew, James C.Y. Dunn, Laurie Reyen, Douglas G. Farmer, Sherin U. Devaskar, Robert Venick, 
											